X4 Pharmaceuticals board members McGirr and Woods resign; audit committee reconstituted

X4 Pharmaceuticals, Inc

David McGirr and R. Keith Woods resigned from the board effective August 22, 2025, with no disagreement.
Michael Wyzga appointed as chair of the audit committee.
Francoise de Craecker and Gary Bridger appointed as members of the audit committee.
Resignations cover all committees; departure not related to operations, policies, or practices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.